Announcement of awarded tender
For further information please download the pdf file attached to this article.
Investigating inhibitor development in patients with Hemophilia A
Lecture on state-of-the-art of the SIPPET Study presented by P.M. Mannucci, sponsored by Grifols, Kedrion and LFB
Festival della Salute: conference on self-sufficiency supported by Kedrion
Plasma and plasma-derived products take centre stage at a workshop with all the stakeholders of the Italian Blood System
Humanitarian projects: a new donation of factor VIII and IX to Afghanistan
The donation has been made under a partnership between CNS and Milan’s Fondazione Ca’ Granda
Kedrions’ immunoglobulin approved for the treatment of CIDP in Italy
The ruling published by AIFA in the Official Journal, on 23rd June 2014
“Il giallo dell’autosufficienza”, Kedrion supports the National CRS convention
Health authorities, healthcare professionals and donors talk about plasma and plasma-derived products
Kedrion, one of Italy’s most innovative companies in 2014
The MIT Technology Review Italia’s award given in Bologna on May 11
EmoKed, software for traceability, transparency and efficiency
The new online platform developed by Kedrion provides strategic support to the Italian Transfusion System
5-year unrated EUR 300 million bond successfully launched
The bonds have been placed with leading international institutional investors and will be listed on the Irish Stock Exchange
Kedrion Group approves 2013 financial statements
Achieved results of 425 million euros turnover and a 25% profitability